Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-24 @ 10:21 PM
NCT ID:
NCT04937335
Eligibility Criteria:
Inclusion Criteria:
* receive resective operation with a pathological diagnosis of craniopharyngioma in our hospital
* enter our hospital between January 2013 and February 2021
Exclusion Criteria:
* have a non-craniopharyngioma or unverified pathological diagnosis at discharge
* have received surgical or radiological treatment on the sellar region
* receive treatment of coagulation modulation, immunosuppressive agents or chemotherapeutic drugs
* combine with other clinical emergencies including acute myocardial infarction, cerebral stroke, trauma and sepsis at admission
* have been diagnosed with other tumors, hematological diseases, autoimmune diseases, liver failure or renal failure
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04937335
Study Brief:
Protocol Section:
NCT04937335